Literature DB >> 34469401

Initial Fluid Balance Associated Outcomes in Children With Severe Sepsis and Septic Shock.

Ayman Al-Eyadhy1, Gamal Hasan, Mohamad-Hani Temsah1, Sara Alseneidi2, Malak Alalwan2, Fatimah Alali2, Ali Alhaboob1, Majed Alabdulhafid1, Fahad Alsohime1, Mohamed Almaziad1, Ali Mohammed Somily3.   

Abstract

INTRODUCTION: Net fluid balance and its role in sepsis-related mortality is not clear; studies suggest that aggressive fluid resuscitation can help in treatment, whereas others consider it is associated with poor outcomes. This study aimed to clarify the possible association of initial 24 hours' fluid balance with poor outcomes in pediatric patients with sepsis.
METHODS: Retrospective data analysis included pediatric patients admitted with suspected or proven sepsis or septic shock to pediatric intensive care unit (PICU) of a tertiary care teaching hospital in Saudi Arabia.
RESULTS: The study included 47 patients; 13 (28%) died, and mortality rate was significant in children with neurologic failure (P < 0.02), mechanical ventilation within 24 hours of admission (P < 0.03), leukopenia (P < 0.02), abnormal international normalized ratio (P < 0.02), initial blood lactate levels higher than 5 mmol/L (P < 0.02), or positive fluid balance at 24 hours of admission to the PICU (P < 0.001).
CONCLUSION: Among children with sepsis and/or septic shock, there is significant association between mortality and initial high blood lactate levels and positive fluid balance at 24 hours from admission to the PICU.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2022        PMID: 34469401     DOI: 10.1097/PEC.0000000000002520

Source DB:  PubMed          Journal:  Pediatr Emerg Care        ISSN: 0749-5161            Impact factor:   1.454


  1 in total

1.  Current Practice of Fluid Maintenance and Replacement Therapy in Mechanically Ventilated Critically Ill Children: A European Survey.

Authors:  Ismail Arrahmani; Sarah A Ingelse; Job B M van Woensel; Reinout A Bem; Joris Lemson
Journal:  Front Pediatr       Date:  2022-02-23       Impact factor: 3.418

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.